CSN Login
Members Online: 3

You are here

Opening of enrollment in US of Phase I CRC study announced today at

coloCan
Posts: 1956
Joined: Oct 2009

www.prnewswire.com

title: Oncolytics Biotech Inc Announces Opening of Enrollment in US Phase I Colorectal Cancer Study

This involves using REOLYSIN (this firm's drug) in combo with FOLFIRI for those with oxaliplatin refractory/intolerant Kras mutant CRC

Meanwhile,a company called Pro-Pharma seems to be getting positive feedback from FDA for Phase III trial design for DAVANAT, which is its CRC drug in progress.......see:businesswire.com

dont know if this will help anyone......steve

Lovekitties's picture
Lovekitties
Posts: 3372
Joined: Jan 2010

You are a gem to keep up with all the latest and greatest and keeping everyone here in the loop.

Thanks for being you.

Marie who loves kitties

Subscribe to Comments for "Opening of enrollment in US of Phase I CRC study announced today at"